Accesso libero

Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors

, , , , , , , , ,  e   
14 apr 2024
INFORMAZIONI SU QUESTO ARTICOLO

Cita
Scarica la copertina

Ingenerf, Maria
Department of Radiology, University Hospital, LMU MunichGermany
Auernhammer, Christoph
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Department of Internal Medicine 4, University Hospital, LMU MunichMunich, Germany
Lorbeer, Roberto
Department of Radiology, University Hospital, LMU MunichGermany
Winkelmann, Michael
Department of Radiology, University Hospital, LMU MunichGermany
Mansournia, Shiwa
Department of Radiology, University Hospital, LMU MunichGermany
Mansour, Nabeel
Department of Radiology, University Hospital, LMU MunichGermany
Hesse, Nina
Department of Radiology, University Hospital, LMU MunichGermany
Heinrich, Kathrin
Department of Medicine III, University Hospital, University of MunichMunich, Germany
Ricke, Jens
Department of Radiology, University Hospital, LMU MunichGermany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Berger, Frank
Department of Radiology, University Hospital, LMU MunichGermany
Schmid-Tannwald, Christine
Department of Radiology, University Hospital, LMU MunichGermany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Lingua:
Inglese
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia